Chaired by Dr. Scott Berry and Prof. Srikala Sridhar, this exclusive international in-person and virtual flagship event will present a summary of the most significant treatment advances in Genitourinary and Gastrointestinal malignancies presented at major international events in 2022 and 2023.
- To discuss pivotal trials and research presented in the different disease sites.
- To review the current standard of care for key malignancies.
- To discuss the current controversies in the management of specific GU & GI cancers.
Friday, April 14, 2023
7:00 a.m. – 5:00 p.m.
In Person & Free Virtual Registration Options Below:
For the safety of our registrants and the vulnerable patient population they serve, we strongly encourage the use of masks by all attendees. This is also a reminder that all attendees must be fully vaccinated against COVID-19 by the time of the event.
Registration for Healthcare professionals can be completed above. Industry representatives (both sponsor and non-sponsor) must contact Kelly Allan at kelly@oncologyeducation.ca for registration and sponsorship opportunities.
Join Us Live In Person at the
Pan Pacific, Toronto
Scientific Agenda
7:00am – 8:00am
Registration and Breakfast Buffet
8:00am – 8:45am
Seagen Breakfast Symposium: Navigating new treatment options and a changing paradigm in metastatic bladder cancer – Dr. Sebastien Hotte
8:45am – 8:55am
Welcome Address – Dr. Scott Berry & Prof. Srikala Sridhar
8:55am – 9:20am
Bladder Cancer – Dr. Maria Jiang
9:20am – 9:45am
Kidney Cancer – Dr. Daniel Heng
9:45am – 10:15am
Meet the GU Professors – Dr. Daniel Heng, Dr. Sebastien Hotte, Dr. Nazanin Fallah-Rad & Dr. Maria Jiang (Not Live Streamed)
10:15am – 10:35am
Networking Break & Sponsor Exhibits
10:35am – 11:00am
Prostate Cancer – Dr. Sebastien Hotte
11:00am – 11:30pm
Case-Based Discussion in GU Cancers – Moderated by Dr. Nazanin Fallah-Rad
11:30am – 12:00pm
LUNCH BUFFET & NETWORKING BREAK
12:00pm – 12:45pm
Pfizer Lunch Symposium – Leveraging a Biomarker Driven Approach in mCRC Treatment – Dr. Brandon Sheffield & Dr. Kim Ma
12:45pm – 1:30pm
BMS Mid-Afternoon Symposium: Immunotherapy in Metastatic Upper GI Adenocarcinomas: Addressing Patient Needs with the Support of New Data – Dr. Christine Brezden-Masley & Teresa Tiano
1:30pm – 2:00pm
Meet the GI Professors – Dr. Yoo-Joung Ko, Dr. Suneil Khanna (Not Live Streamed)
2:00pm – 2:20pm
Networking Break & Sponsor Exhibits
2:20pm – 2:45pm
Colorectal Cancer – Dr. Scott Berry
2:45pm – 3:10 pm
Pancreatic Cancer – Dr. Yoo-Joung Ko
3:10pm – 3:35 pm
Gastroesophageal Cancer – Dr. Elena Elimova
3:35pm – 4:00 pm
Hepatobiliary Cancer – Dr. Ravi Ramjeesingh
4:00pm – 4:30 pm
Case-Based Presentation in GI Cancers – Moderated by Dr. Suneil Khanna
4:30pm – 4:40pm
Closing Remarks – Dr. Scott Berry & Prof. Srikala Sridhar
About the Faculty
Dr. Scott Berry
Conference Chair
Dr. Scott Berry is a medical oncologist and Professor and Department Head in the Queen’s University Department of Oncology.He is the Cancer Program Medical Director at the Cancer Centre of Southeastern Ontario at the Kingston Health Sciences Centre.
Dr.Berry is an active participant in clinical research in GI cancer. He is the Co-Chair of the GI Disease Site Group of the CCO Program in Evidence Based Care.
Dr. Berry loves teaching, has won several teaching awards and is a past Chair of the Royal College of Physicians and Surgeons of Canada Specialty Committee for Medical Oncology.
His other academic interest is the bioethical issues surrounding the care of people with cancer, in particular the ethical issues surrounding funding new and expensive cancer medications. Dr. Berry has a Master’s degree in Bioethics from the University of Toronto. He is the former ethics advisor to the pan-Canadian Oncology Drug Review and has served on the ASCO Ethics Committee.
Prof. Srikala Sridhar
Conference Chair
Dr. Srikala Sridhar is a Professor in the Department of Medicine at the University of Toronto and a Medical Oncologist at Princess Margaret Cancer Center. She is the Site Lead for the Genitourinary Medical Oncology site group. Nationally, she is the Chair of the Genitourinary Medical Oncologists of Canada and Vice Chair of the Medical Advisory Board of Bladder Cancer Canada. She is a member of the Canadian Clinical Trials Group, Genitourinary Disease Site Executive Committee and the US NCI Bladder Cancer Task Force. Her main research focus is in the area of new drug development in advanced genitourinary cancers. She has been the principal investigator or co-investigator on several key practice-changing trials in genitourinary oncology and has published extensively in the field. She is regarded as an international expert in the field of advanced bladder cancer. In addition, in 2011, she received a University of Toronto, Postgraduate Medicine Teaching Award and in 2020, the University of Toronto, Department of Medicine, Robert Hyland Mentorship Award.
Sponsorship
PLATINUM
GOLD
SILVER
